Caricamento...
Patient Satisfaction with AbobotulinumtoxinA for Aesthetic Use in the Upper Face: A Systematic Literature Review and Post-hoc Analysis of the APPEAL Study
BACKGROUND: AbobotulinumtoxinA (AboBoNT-A; Dysport(®); Ipsen, Boulogne-Billancourt, France/Azzalure(®); Galderma, Lausanne, Switzerland) is a botulinum neurotoxin type A approved for aesthetic use in the treatment of glabellar lines in adult patients under 65 years in Europe, the United States, and...
Salvato in:
| Pubblicato in: | J Clin Aesthet Dermatol |
|---|---|
| Autori principali: | , , , , , , , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Matrix Medical Communications
2021
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8211347/ https://ncbi.nlm.nih.gov/pubmed/34221231 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|